FDMT
Price
$4.58
Change
-$0.10 (-2.14%)
Updated
Jan 17 closing price
Capitalization
211.72M
72 days until earnings call
ORMP
Price
$2.28
Change
-$0.04 (-1.72%)
Updated
Jan 17 closing price
Capitalization
91.91M
39 days until earnings call
Ad is loading...

FDMT vs ORMP

Header iconFDMT vs ORMP Comparison
Open Charts FDMT vs ORMPBanner chart's image
4D Molecular Therapeutics
Price$4.58
Change-$0.10 (-2.14%)
Volume$927.66K
Capitalization211.72M
Oramed Pharmaceuticals
Price$2.28
Change-$0.04 (-1.72%)
Volume$137.56K
Capitalization91.91M
FDMT vs ORMP Comparison Chart
Loading...
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FDMT vs. ORMP commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDMT is a Hold and ORMP is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (FDMT: $4.58 vs. ORMP: $2.28)
Brand notoriety: FDMT and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FDMT: 96% vs. ORMP: 80%
Market capitalization -- FDMT: $211.72M vs. ORMP: $91.91M
FDMT [@Biotechnology] is valued at $211.72M. ORMP’s [@Biotechnology] market capitalization is $91.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FDMT’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • FDMT’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than FDMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FDMT’s TA Score shows that 3 TA indicator(s) are bullish while ORMP’s TA Score has 3 bullish TA indicator(s).

  • FDMT’s TA Score: 3 bullish, 4 bearish.
  • ORMP’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, ORMP is a better buy in the short-term than FDMT.

Price Growth

FDMT (@Biotechnology) experienced а -17.03% price change this week, while ORMP (@Biotechnology) price change was -4.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

FDMT is expected to report earnings on May 08, 2025.

ORMP is expected to report earnings on May 28, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FDMT($212M) has a higher market cap than ORMP($91.9M). ORMP YTD gains are higher at: -5.785 vs. FDMT (-17.774). ORMP has higher annual earnings (EBITDA): 9.44M vs. FDMT (-161.94M). FDMT has more cash in the bank: 502M vs. ORMP (142M). ORMP has less debt than FDMT: ORMP (429K) vs FDMT (24.8M). FDMT has higher revenues than ORMP: FDMT (17K) vs ORMP (0).
FDMTORMPFDMT / ORMP
Capitalization212M91.9M231%
EBITDA-161.94M9.44M-1,716%
Gain YTD-17.774-5.785307%
P/E RatioN/A20.73-
Revenue17K0-
Total Cash502M142M354%
Total Debt24.8M429K5,781%
FUNDAMENTALS RATINGS
ORMP: Fundamental Ratings
ORMP
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
85
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
55
SEASONALITY SCORE
1..100
31

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FDMTORMP
RSI
ODDS (%)
Bullish Trend 11 days ago
73%
N/A
Stochastic
ODDS (%)
Bearish Trend 11 days ago
83%
Bullish Trend 11 days ago
82%
Momentum
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
80%
MACD
ODDS (%)
Bullish Trend 11 days ago
78%
Bearish Trend 11 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
78%
Bearish Trend 11 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
84%
Advances
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 13 days ago
82%
Declines
ODDS (%)
Bearish Trend 20 days ago
89%
Bearish Trend 11 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
70%
N/A
Aroon
ODDS (%)
Bearish Trend 11 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PYXS1.500.03
+2.04%
Pyxis Oncology
CTTAY6.860.09
+1.33%
Continental AG
NPSNY39.440.51
+1.32%
Naspers Ltd.
ILIKF0.25N/A
+1.00%
Ilika PLC.
SPGYF6.91-0.02
-0.36%
Whitecap Resources, Inc.

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with QRON. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then QRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
-2.14%
QRON - FDMT
39%
Loosely correlated
N/A
ORMP - FDMT
38%
Loosely correlated
-1.72%
ANNX - FDMT
36%
Loosely correlated
+2.19%
AXON - FDMT
34%
Loosely correlated
+1.37%
SCPH - FDMT
34%
Loosely correlated
-4.09%
More